Cogstate LtdASX: CGS

Cogstate 1H26 Financial Results

· Issued by Cogstate Ltd

Filed with ASX · · 7 pages · English

Cogstate Ltd (ASX:CGS), a global leader in clinical trial endpoint data quality and digital cognitive assessments, today releases its Appendix 4D and Half-Year Report for the half-year ended 31 December 2025 ("1H26"). Cogstate has delivered strong revenue growth and demonstrated maturing operational leverage, positioning Cogstate to capture increasing market share in the rapidly expanding CNS (cen

Cogstate Ltd on 6ix

In the deck

Story so far

Earlier from Cogstate

Later from Cogstate

All Cogstate news releases